Noradrenaline-Induced Relaxation of Urinary Bladder Smooth Muscle Is Primarily Triggered through the β₃-Adrenoceptor in Rats
-
- Obara Keisuke
- Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Toho University
-
- Suzuki Serena
- Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Toho University
-
- Shibata Hiroko
- Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Toho University
-
- Yoneyama Naoki
- Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Toho University
-
- Hamamatsu Shoko
- Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Toho University
-
- Yamaki Fumiko
- Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Toho University
-
- Higai Koji
- Laboratory of Medical Biochemistry, Faculty of Pharmaceutical Sciences, Toho University
-
- Tanaka Yoshio
- Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Toho University
書誌事項
- タイトル別名
-
- Noradrenaline-Induced Relaxation of Urinary Bladder Smooth Muscle Is Primarily Triggered through the β<sub>3</sub>-Adrenoceptor in Rats
この論文をさがす
説明
<p>β-Adrenoceptors are subclassified into 3 subtypes (β1–β3). Among these, β3-adrenoceptors are present in various types of smooth muscle and are believed to play a role in relaxation responses of these muscles. β3-Adrenoceptors are also present in urinary bladder smooth muscle (UBSM), although their expression varies depending on the animal species. To date, there has been little information available about the endogenous ligand that stimulates β3-adrenoceptors to produce relaxation responses in UBSM. In this study, to determine whether noradrenaline is a ligand of UBSM β3-adrenoceptors, noradrenaline-induced relaxation was analyzed pharmacologically using rat UBSM. We also assessed whether noradrenaline metabolites were ligands in UBSM. In isolated rat urinary bladder tissues, mRNAs for β1-, β2-, and β3-adrenoceptors were detected using RT-PCR. In UBSM preparations contracted with methacholine (3 × 10−5 M), noradrenaline-induced relaxation was not inhibited by the following antagonists: atenolol (10−6 M; selective β1-adrenoceptor antagonist), ICI-118,551 (3 × 10−8 M; selective β2-adrenoceptor antagonist), propranolol (10−7 M; non-selective β-adrenoceptor antagonist), and bupranolol (10−7 M; non-selective β-adrenoceptor antagonist). In the presence of propranolol (10−6 M), noradrenaline-induced relaxation was competitively inhibited by bupranolol (3 × 10−7–3 × 10−6 M) or SR59230A (10−7–10−6 M; selective β3-adrenoceptor antagonist), with their pA2 values calculated to be 6.64 and 7.27, respectively. None of the six noradrenaline metabolites produced significant relaxation of methacholine-contracted UBSM. These findings suggest that noradrenaline, but not its metabolites, is a ligand for β3-adrenoceptors to produce relaxation responses of UBSM in rats.</p>
収録刊行物
-
- Biological & Pharmaceutical Bulletin
-
Biological & Pharmaceutical Bulletin 42 (5), 736-743, 2019-05-01
公益社団法人 日本薬学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390845713065270144
-
- NII論文ID
- 130007641460
-
- NII書誌ID
- AA10885497
-
- ISSN
- 13475215
- 09186158
-
- NDL書誌ID
- 029657718
-
- PubMed
- 31061315
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDLサーチ
- Crossref
- PubMed
- CiNii Articles
- OpenAIRE
-
- 抄録ライセンスフラグ
- 使用不可